Not Signed In - NICE Publishes Final Guidance For Aromatase Inhibitors, UK
Wed, 22 Nov 2006 08:00 AM EST
... Aromatase inhibitors (AIs) will be freely available across England and Wales for the 23,000 postmenopausal women diagnosed with hormone receptor-positive (HR+) early breast cancer each year.1 The National Institute for Health and Clinical Excellence (NICE) announced today the final findings of its technology appraisal on the use of AIs in early breast cancer. [click link for full article] ...
Related Topics
- Counseling And Guidance
- CMP
- MAO Inhibitors
- ACE Inhibitors
- COX-2 Inhibitors
- Proton-pump Inhibitors
- Development of antibodies (inhibitors) to fibrinogen with treatment
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Pranic healing
- Midwife
- Pulmonary Fibrosis
- Sex Education
- Complementary medicine
- Pancreatic Cancer
- Births, Deaths & Marriages
- Assisted Living
- Homeopathy
- Homelessness
- Epinephrine Inhalation Solution
- Bmi
email this page
print this page
bookmark this page
feedback on this page
